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Introduction
Young children and children with various developmental
delays frequently require sedation to complete nonpainful
procedures like ABR, bone scan, and MRI. Keeping them
motionless during the procedure is important to attain
accurate results. Chloral Hydrate, the standard sedative agent
prescribed for many years for such studies is not available
anymore in the United States. This has resulted in signiﬁcant
increase in interest of using propofol for these diagnostic
procedures. Propofol possesses many of the qualities of an
ideal sedative drug. These properties are rapid onset, short
duration of action, high clearance rate, minimum drug accu-
mulation, and no active metabolite.1
To maintain a deep sedation, propofol can be given using
an intermittent bolus (IB) technique or a continuous infusion
technique with supplemental boluses as needed.2–4 The
infusion pump allows the sedating physician to titrate and
maintain a constant therapeutic plasma drug level that
minimizes theﬂuctuations of drug concentration in the blood
and results in smooth deep sedation. In either technique, a
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Abstract Objective A comparison of intermittent bolus (IB) versus continuous infusion of
propofol for deep sedation.
Material and Methods A retrospective review of patients sedated for Auditory
Brainstem Response (ABR)/nuclear medicine studies between September 2008 and
February 2015. A ketamine bolus (0.5 mg/kg< 20 kg, 0.25 mg/kg> 20 kg) followed by
propofol bolus of 1 mg/kg over 2 minutes. In the IB group, maintenance of deep
sedation was with incremental bolus of 10 to 20 mg of propofol. In continuous infusion
group (CG), maintenance was with a continuous infusion of 83 mcg/kg/min of propofol.
Results Of the 326 cases completed, 181 were in CG group and 145 were in IB group.
There were no statistical differences in patient’s age, weight, and American Society of
Anesthesiologist (ASA) classiﬁcation. The cardiovascular and respiratory parameters in
the two groups were not different statistically. Mean total propofol dose was higher in
CG group versus IB group (CG 7.6 mg  3.6 mg, IB 6.5 mg  3.6 mg; p ¼ 0.008).
Procedure time in CG group was longer by 8 minutes compared with IB group (CG
49.8 min  25.4 min versus 42.3 min  19.2 min; p ¼ .003). CG group has both
shorter recovery time (CG 8.1 min  4.7 min versus IB 10.0 min  8.5 min;
p ¼ 0.01) and discharge time.
Conclusion Satisfactory sedation and completion of the procedure was accomplished
with both sedation protocols.
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bolus dose is required to ﬁll the volume of distribution of the
drug. The review of anesthesia literature, although unsettled,
reveals that there is a possibility to gain desired sedation
levels with lesser drug and a more rapid recovery when a
continuous technique is used.5 The purpose of this retrospec-
tive studywas to compare administration of propofol using an
incremental bolus technique versus continuous infusion in
patients undergoing ABR/nuclear medicine studies. In this
study, dosage, hemodynamics, procedure, recovery, and dis-
charge times were reviewed.
Methods
This is an institutional board approved retrospective electronic
chart review of all the patients sedated with propofol for ABR/
nuclear medicine studies between September 2008 and Feb-
ruary 2015 at Riley Hospital for Children at Indiana University.
Initially, we sedated patients using IB method. The change in
group practice occurred after the infusion pumpwas available
to sedate these patients using continuous propofol infusion. A
total of 326 patient charts were reviewed in both groups and
no patient sedated for this procedure was excluded. Data
included patient demographics, underlying and acute diagno-
sis, and occurrence of adverse events, physiologic variables,
drug dosages, procedures, sedation, and recovery times. Our
facility has an intensivist-based sedationprogram that adheres
to policies and guidelines based on the recommendations by
the Joint Commissions on Accreditation of Health Care Orga-
nization (JCAHO) and American Academy of Pediatrics
(AAP).6,7 Patients are prescreened via phone interview by a
sedation nurse with a parent/guardian or via a review of the
primary care physician’s chart. The sedation nurses and physi-
cians also assessed patients at the time of sedation.
A peri-procedure process is standard for all the children
being sedated, including the telephone conversation with the
family prior to the procedure date, a quiet room near the
sedation suite, minimal separation from the attachment ﬁgure
(such as themother), use of distraction techniques such as iPad
games and music for IV and monitoring leads placement, and
the option of oral or intranasal medication for IV placement.
Patients were given a ketamine bolus (0.5 mg/kg < 20 kg,
0.25 mg/kg > 20 kg) followed by induction of deep sedation
by propofol bolus of 1 mg/kg over 1 to 2 minutes. In the IB
group, maintenance of deep sedation was achieved with IB of
10 to 20 mg of propofol. The amount and timing of the bolus
was at the judgment of sedating physician. The IBwas given in
anticipation to the response to a stimulus or if there were
signs of inadequate sedation like lowRamsay scale, increasing
heart rate, respiratory rate, blood pressure, making sounds,
and movements.
In the continuous infusion group (CG), sedation was
maintained with a propofol infusion of 83 mcg/kg/min. The
infusion rate of 83 mcg/kg/min was selected based on the
existing literature.8 A minimum Ramsay (RSS) score of 4 was
targeted. RSS is clinically derived sedation score generally
accepted as a tool for assessing depth of sedation along with
monitoring of vital signs.9 The continuous rate could be
increased or decreased as necessary. The increase in rate
occurs only if the patient has signs suggestive of insufﬁcient
sedation (such as low Ramsay score, increased heart rate,
blood pressure, respiratory rate, or excessive movement). The
infusion ratewas decreasedwhen therewere signs suggestive
of development of anesthetic state like Ramsay score of 6,
decreasing blood pressure, respiratory rate, hypotension, or
both. The sedation team agreed upon protocol and was
instructed to make minimal changes to infusion rate; howev-
er, the sedating physician had complete discretion of proce-
dural sedation management. Throughout the procedure,
patients were monitored continuously by a dedicated seda-
tion nurse via continuous pulse oximetry, heart rate, and
noninvasive blood pressure monitoring, and nasal capnog-
raphy. The sedating physician was present in the room
throughout the entire procedure and was the one adminis-
tering propofol in intermittent group. Patients were moni-
tored until they were awake, drinking ﬂuids and had a
minimal alderete score of nine points.10
Peak onset of sedation is the time from start of loading
dose to achievement of a Ramsay score of 4. Procedure time is
deﬁned as the time from achieving the acquired Ramsay score
to the end of procedure (stoppage of drug administration).
Recovery time was deﬁned as the time from the end of the
procedure to actual time the patient was back to his baseline
status. Discharge time was deﬁned as the time of leaving the
recovery room after patient recovery to his baseline status.
The two patient groups were compared with respect to
demographic, clinical, and time variables. Data was analyzed
using dedicated statistical software, SAS v.9.3 (SAS Institute,
Cary, NC). Propofol induced vital sign changes from baseline
in each group were compared using standard Student’s t-test
or the Mann–Whitney rank sum test, depending on whether
the data was normally distributed or skewed, for continuous
data, and Fisher’s Exact Test for categorical data. Data was
presented as mean standard deviation, unless otherwise
speciﬁed. A p-value of 0.05 was considered signiﬁcant. Com-
plications (apnea, desaturation, hypotension) and nuclear
medicine tests were also analyzed to see if there were differ-
ences between treatment groups, as the participants may be
different between test/complication groups, or these compli-
cations may attenuate the outcomes.
Results
Three hundred twenty-six patients were sedated, of which
181 were in CG group and 145 were in IB group. In CG group,
the most common procedure was ABR n ¼ 111 (61%) fol-
lowed by MIBG n ¼ 58 (32%) and bone scan n ¼ 11 (6.1%).
While in IB group, the most common procedure was also ABR
n ¼ 68 (47%) followed by bone scan n ¼ 57 (39%) and MIBG
n ¼ 20 (14%). In both groups, age (CG 2.7 yr  2.6 yr versus
IB 2.8 yr  1.8 yr; p ¼ 0.90) andweight (CG 13.5 kg  5.0 kg
versus IB 14.0 kg  5.3 kg; p ¼ 0.31) of the patients were
comparable. The CG group has 25 more female patients than
IB group, but the difference was not statistically signiﬁcant
(►Table 1). Most of the patients in both groups were in ASA II
and only one patient sedated in IB group was in ASA IV
(►Table 2). All the patients in both groupsweremaintained in
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deep state of sedation and completed procedures with 100%
success.
Respiratory depression was deﬁned as decrease in respira-
tory rate >20% from the baseline and incidence of hypoventi-
lationwas 27 (14.9%) and 26 (17.9%) in CG group and IB group,
respectively, and didn’t reach any signiﬁcant statistical differ-
ence among thegroup.Onepatient in each grouphas an apneic
episode and mild hypoxemia (SaO2 < 90%) occurred in 17%
(n ¼ 24) of the patients in IB group versus 8%(n ¼ 15) in CG
group. All these patients responded to supplemental oxygen
via nasal cannula and required no bag and mask ventilation.
Hypotension was deﬁned as a decrease in systolic blood
pressure >20% from the baseline.11 The incidence of hypo-
tension between the groups was not statistically different
(p ¼ 0.4). Although a drop in blood pressure was commonly
observed, medical intervention was not needed.
During the entire procedure, none of the patients had heart
rates belowpreviously published age-speciﬁc reported normal
values,10 nor did the lowest recorded heart rate fall 20%
below the given baseline average range.11 Bradycardia (HR <
60/min), as deﬁned according to Pediatric Advance Life Sup-
port (PALS) guidelines, was not observed in any child. Mean
total dose of propofol was higher in CG group versus IB group
(CG 7.6 mg  3.6 mg, IB 6.5 mg  3.6 mg; p ¼ 0.008) consis-
tent with longer procedure time of CG group. Procedure time
in CG groupwas longer by8minutes comparedwith IB group
(CG 49.8 min  25.4 min versus IB 42.3 min  19.2 min;
p ¼ .003) (►Fig. 1). Despite longer procedure time, CG group
has shorter recovery times (CG 8.18 min  4.7 min versus IB
10.0 min  8.5 min; p ¼ 0.018). Discharge time was also
shorter in CG group butdidn’t reach to a statistically signiﬁcant
difference between the groups (p ¼ 0.15) (►Table 3, ►Fig. 2).
As procedure time may inﬂuence the medication dose, we
have analyzed the dose outcomes to determine if there are
differences between the treatment groups after adjusting for
the length of procedure time. This does attenuate the asso-
ciations: total dose (CG 7.2 mg versus IB 7.0 mg, p ¼ .46);
propofol (CG 6.7 mg versus IB 6.5 mg, p ¼ .49); ketamine (CG
0.4 mg versus IB 0.4 mg, p ¼ .22).
For complications and nuclear medicine tests (►Table 4),
although there was a signiﬁcant difference in the complica-
tion desaturation between treatment groups (8% infusion
pump group versus 17% no-pump group; p ¼ 0.025), the
addition of this variable did not attenuate themain outcomes.
There were also signiﬁcant differences in the proportion of
Table 2 ASA classiﬁcation
Continuous
sedation
(n ¼ 181)
Intermittent
sedation
(n ¼ 145)
p-Value
ASA
I 4 (2.2) 1 (0.7) 0.372
II 163 (90.1) 135 (93.1)
III 14 (7.7) 8 (5.5)
IV 0 (0) 1 (0.7)
Complications
(yes)
16 (8.8) 24 (16.6) 0.042
Abbreviation: ASA, American Society of Anesthesiologist.
Note: Values are frequency (percent) with p-values coming from Fisher’s
Exact Test.
Fig. 1 Total sedation time.
Table 1 Demographics
Continuous
sedation
(n ¼ 181)
Intermittent
sedation
(n ¼ 145)
p-Value
Age (years) 2.78 (2.66) 2.81 (1.81) 0.903
Sex (female) 91 (50.3) 66 (45.5) 0.435
Weight (kg) 13.45 (5.09) 14.03 (5.37) 0.317
Note: Values are mean (standard deviation) for continuous variables and
frequency (percent) for categorical variables. p-Values are from Stu-
dent’s t-test for continuous variables and Fisher’s Exact Test for cate-
gorical variables.
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those with a bone scan and MIBG, as well, but these, too, did
not attenuate themain outcomes (data not shown), indicating
that complications did not adjust the associations found
between groups for our main variables of interest. Adjusted
models were performed using ANCOVA models, to adjust for
the covariates listed.
Discussion
An IB of sedative medication is a standard method to provide
procedural sedation for short-term painful procedures and
also has been used successfully to provide sedation in nonin-
vasive prolonged procedures like ABR and bone scan. The
potential disadvantages associated with this technique in-
clude hypoventilation, apnea, and ﬂuctuation in blood pres-
sure and heart rate. Another alternative method for sedative
medication delivery is that of a continuous infusion. Propo-
nents of continuous infusion technique suggest a decrease in
potential adverse effects due to minimal plasma drug con-
centration variability. Importantly, the infusion can easily be
titrated up or down in response to clinical signs.12
For noninvasive procedures like ABR or nuclear medicines
studies, the study quality depends on the elimination of
patient movement during the study. Younger patients or
those with developmental delay are usually unable to coop-
erate and sedation is required. The ideal agent used for
sedation in those procedures should have a rapid onset of
action, short half-life and a safety proﬁle with low risk of
potential complication (hemodynamic instability and respi-
ratory depression). Several medications have been used
including narcotics, benzodiazepines, ketamine, pentobarbi-
tal, and chloral hydrate, but propofol use has recently
achieved immense favorability.13 Propofol is a rapidly acting
sedative–hypnotic with a shorter duration of action (because
of rapid equilibration between plasma and the brain) and a
subsequent short recovery.14 Because of these properties,
propofol can be used for outpatient sedation for noninvasive
procedures effectively. As reported in previous studies, inad-
equate sedation during noninvasive procedures (MRI) oc-
curred in 5 to 15% of cases resulting in failure to complete
the study in 3.7% of the cases.15,16 In our study, both sedative
techniques using propofol provided satisfactory conditions to
complete the procedure successfully. Respiratory events con-
stitute a large proportion (5.5–31.7%) of sedation complica-
tion in children.17,18 We observed the similar level of
Table 3 Total propofol dose and sedation time
Continuous sedation (n ¼ 181) Intermittent sedation (n ¼ 145) p-Value
Total dose (mg/kg) 7.61 (3.63); 6.54 (3.61); 0.008
6.67 (2.47–21.56) 5.20 (1.62–23.70)
Propofol dose (mg/kg) 7.16 (3.63); 6.10 (3.60); 0.009
6.25 (2.00–21.10) 4.78 (1.15–23.20)
Propofol dosage adjusted to
time length(mcg/kg/min)
6.78 6.58 0.49
Ketamine dose (mg/kg) 0.45 (0.07); 0.44 (0.10); 0.231
0.47 (0.22–0.93) 0.47 (0.22–1.00)
Total time (min) 65.67 (26.18); 60.94 (21.64); 0.075
59 (26–150) 56 (24–130)
Procedure time (min) 49.86 (25.45) 42.30 (19.29); 0.003
44 (12–129) 36 (12–102)
Recovery time (min) 8.18 (4.75); 10.06 (8.52); 0.018
7 (1–26) 9 (0–75)
Discharge time (min) 7.64 (4.30); 8.58 (6.94); 0.153
5 (0–25) 5 (0–55)
Note: Propofol dose, total infusion dose only; Total dose, propofol bolus for induction þ maintenance infusion.
Values are mean (standard deviation); median (range) with p-values coming from Student’s t-test.
Table 4 Sedation related complications
Continuous
sedation
Intermittent
sedation
p-Value
During sedation
(any)
16 (8.8) 24 (16.6) 0.0416
Desat (yes) 15 (8.3) 24 (16.6) 0.0258
Apnea (yes) 1 (0.6) 1 (0.7) 1.0000
Hypotension (yes) 0 (0) 1 (0.7) 0.4448
Vomiting (yes) 0 (0) 0 (0) n/a
Bradycardia (yes) 0 (0) 0 (0) n/a
Transfer to
higher care
0 (0) 0 (0) n/a
Other (yes) 1 (0.6) 0 (0) 1.0000
Note: Values are frequency (percent) and p-value is from Fisher’s Exact
Test.
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hypoxemia, but the occurrence was higher in IB group (17%)
versus CG group (8%). This frequency of hypoxemia appears to
depend on the dose and rate of administration with a higher
incidence reported with larger doses.19,20 This could be a
possible explanation of higher occurrence of hypoxemia in IB
group. We observed one apneic episode in each group
resolved spontaneously using jaw-thrust maneuver. All of
the patients who developed hypoxemia responded to simple
airway positioning and use of supplemental oxygen and did
not require bag mask ventilation.
Bradycardia has been described as a possible adverse effect
of propofol when administered in IBs or as infusion. In our
study, the incidence of bradycardia (deﬁned as a decrease in
heart rate >20% from baseline) was only 1% in both groups
and didn’t require any intervention.21,22 Propofol has also
been shown to cause transient decrease in blood pressure
(deﬁned as >20% decrease in blood pressure from baseline)
when administered as a bolus or prolonged infusion.21,22 The
incidence was low in CG group (2.3% vs 3.5%), which could be
due to awell-known sympathetic inhibitory effect of propofol
and consistent with observation reported in other studies.
None of the hypotensive episodes were considered clinically
signiﬁcant and required any intervention.
It has been suggested that less propofol is required to
maintain sedation with continuous infusion.23 This was not
the case in our study, which showed an increased mainte-
nance dose of propofol for the patient receiving a continuous
infusion (►Table 3). As mentioned in the results, the proce-
dure time in CG group was 20% longer than the IB group .This
prolonged procedure time in CG group could be due to 40%
more ABR cases in this group, which is one of the lengthiest
noninvasive procedures performed. This could be a possible
explanation of increased maintenance dose of propofol in CG
group as the longer the procedure, the more of the drug you
need to keep the patient sedated. Despite more propofol
being used in patients sedatedwith using continuous infusion
techniques, the recovery time was shorter; however, there
was no difference between groups in time to meet discharge
criteria after early recovery.
The limitations of our study include its retrospective nature
and single center experience. The current study presents a 100%
success with propofol for noninvasive procedure using either
intermittentor continuous infusionof administration. It couldbe
asserted that the reportedefﬁcacy is due to theuseof intensivist-
based specialized sedation team rather than to delivery of
propofol itself. This is reasonably true to some extent as speciali-
zation and experience should increase both success and efﬁcien-
cy. In spite of that, this can be stated with conﬁdence; much of
the reported success is speciﬁcallya functionofpropofol. This is a
descriptive study and few, if any conclusion can be drawn about
safety, is also underpowered to comment on safety, because the
occurrence of serious sedation-related side effects are, fortu-
nately, rare.24 Additional prospective studies of the sedation for
noninvasive procedures in children using a greater number of
patients are warranted to provide a true idea of safety.
Conclusion
This study, although ﬁnds an advantage of ease of adminis-
tration of drug and shorter recovery time in the CG, indicates
there are no signiﬁcant differences in satisfactory sedation
and quality of diagnostic studies with both techniques.
Conﬂict of Interest
None.
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